Animal models of rheumatoid arthritis. Clues to etiology and treatment
- PMID: 2009677
Animal models of rheumatoid arthritis. Clues to etiology and treatment
Abstract
Animal models of rheumatoid arthritis (RA) provide useful systems for the characterization of the immunopathogenic mechanisms of chronic inflammatory synovitis. Although at least eight models have been described, the adjuvant arthritis, streptococcal cell wall-induced arthritis, and collagen-induced arthritis models have provided the most useful insights. Each of these three models has contributed clues to our understanding of RA and have yielded promising new approaches to treatment. These include combination pharmacotherapy, antigen-specific therapy, cell-specific therapy, and monoclonal antibody therapy. All of these immunotherapeutic interventions have been shown to be beneficial in one or more animal systems. This suggests that future therapies for RA and other human autoimmune diseases may be more immunoselective and, potentially, less toxic.
Similar articles
-
Combination therapy in rheumatoid arthritis: the animal model perspective.J Rheumatol Suppl. 1996 Mar;44:56-60. J Rheumatol Suppl. 1996. PMID: 8833054 Review.
-
Clues provided by animal models of arthritis.Rheum Dis Clin North Am. 1987 Aug;13(2):307-18. Rheum Dis Clin North Am. 1987. PMID: 3321213 Review.
-
Contribution of genetic studies in rodent models of autoimmune arthritis to understanding and treatment of rheumatoid arthritis.Genes Immun. 2007 Oct;8(7):523-31. doi: 10.1038/sj.gene.6364419. Epub 2007 Aug 16. Genes Immun. 2007. PMID: 17703178 Review.
-
Predictivity and sensitivity of animal models of arthritis.Autoimmun Rev. 2008 Oct;8(1):73-5. doi: 10.1016/j.autrev.2008.07.029. Epub 2008 Aug 15. Autoimmun Rev. 2008. PMID: 18708167 Review.
-
A molecule basis for the HLA association in rheumatoid arthritis.Rev Immunogenet. 2000;2(1):81-7. Rev Immunogenet. 2000. PMID: 11324696 Review.
Cited by
-
Protective effects of indomethacin and cyclophosphamide but not of infliximab on liver metabolic changes caused by adjuvant-induced arthritis.Inflammation. 2011 Dec;34(6):519-30. doi: 10.1007/s10753-010-9259-3. Inflammation. 2011. PMID: 20878352
-
Effect of the COX-2 selective inhibitor l-745,337 on inflammation and organ prostaglandin E2 (PGE2) levels in adjuvant arthritic rats.Inflammation. 2000 Dec;24(6):533-45. doi: 10.1023/a:1007025423232. Inflammation. 2000. PMID: 11128051
-
A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.J Interferon Cytokine Res. 2011 Dec;31(12):927-40. doi: 10.1089/jir.2011.0094. J Interferon Cytokine Res. 2011. PMID: 22149412 Free PMC article. Review.
-
Thermal hyperalgesia and light touch allodynia after intradermal Mycobacterium butyricum administration in rat.Inflammation. 2003 Oct;27(5):293-9. doi: 10.1023/a:1026076426664. Inflammation. 2003. PMID: 14635786
-
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy.J Biomed Biotechnol. 2011;2011:569068. doi: 10.1155/2011/569068. Epub 2010 Dec 28. J Biomed Biotechnol. 2011. PMID: 21253435 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical